Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports
Author(s)
Alqahtani Z1, Guo JJ2, Wigle PR2
1University of Cincinnati, Florence , KY, USA, 2University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH, USA
OBJECTIVES: The rate of serious adverse events such as death, disability, and
life-threatening illness associated with COVID-19 vaccines is not fully described. Moreover, head-to-head comparison studies of COVID-19 vaccines are scarce, therefore, in this study, safety profile of COVID-19 vaccines was assessed as compared to seasonal influenza vaccines.METHODS: CDC/FDA Vaccine Adverse
Event Reporting System database was searched for any adverse events associated with COVID-19 and seasonal influenza vaccines that available in the USA. Age, gender, type of vaccines, adverse events symptoms and types were extract from January 2020 and March 2021. Frequency and rate were calculated according to the vaccine type.RESULTS: 434,486 cases of adverse events following receiving all
COVID-19 vaccines and 10,959 cases seasonal influenzas vaccines were reported. Average age of COVID-19 vaccines recipients was 45 years (SD 16.31) ≥ 60% were females. While seasonal influenza vaccine recipients average age was 25 years (SD 18.82) and ≥ 51% were females. Serious adverse events, i.e., emergency room visits, death, disability, and life threating illness, among COVID-19 vaccines recipients were reported < 2% compared to 4.14% among seasonal influenza vaccines recipients were. Also, Hospitalization rate was up to 7% among admitted adverse events cases among COVID-19 vaccines recipients compared to 8.57%. CONCLUSION: Available data indicates high safety profile for current COVID- 19 vaccines in the USA. We engorge taking the vaccine to overcome the COVID-19 pandemic.Conference/Value in Health Info
2022-05, ISPOR 2022, Washington, DC, USA
Value in Health, Volume 25, Issue 6, S1 (June 2022)
Code
EPH174
Topic
Epidemiology & Public Health
Topic Subcategory
Safety & Pharmacoepidemiology
Disease
No Additional Disease & Conditions/Specialized Treatment Areas